DXB.AX Gross Margin

The Gross Margin of Dimerix Ltd (DXB.AX) is 60.00%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

DXB.AX Gross Margin - Historical Value

Date	Value
2024-06-30	60.00%
2023-06-30	323500.00%
2022-06-30	222000.00%

DXB.AX Gross Margin - Peers Comparison

Ticker	Name	Value
ATX.AX	Amplia Therapeutics Ltd	92.42%
CDY.AX	Cellmid Ltd	6367.69%
PAR.AX	Paradigm Biopharmaceuticals Ltd	99.86%
SCU.AX	Stemcell United Ltd	-2.79%
IMU.AX	Imugene Ltd	100.00%
KZA.AX	Kazia Therapeutics Ltd	77.60%
TLX.AX	Telix Pharmaceuticals Ltd	61.79%
VBS.AX	Vectus Biosystems Ltd	65.98%
ATH.AX	Alterity Therapeutics Ltd	19900.00%
BNO.AX	Bionomics Ltd	7775.20%
CUV.AX	Clinuvel Pharmaceuticals Ltd	101.16%
TDL.AX	TBG Diagnostics Ltd	57.95%
EX1.AX	Exopharm Ltd	4.52%
RAC.AX	Race Oncology Ltd	-1165.00%
BIT.AX	Biotron Ltd	-120.34%
LCT.AX	Living Cell Technologies Ltd	44.33%
ACW.AX	Actinogen Medical Ltd	7775.20%
NSB.AX	NeuroScientific Biopharmaceuticals Ltd	87.52%
PAB.AX	Patrys Ltd	100.00%
PYC.AX	PYC Therapeutics Ltd	-734868.00%
CYP.AX	Cynata Therapeutics Ltd	85.71%
HXL.AX	Hexima Ltd	89.29%
IVQ.AX	Invitrocue Ltd	47.13%
OPT.AX	Opthea Ltd	-53.89%
IMM.AX	Immutep Ltd	-933.05%
MDC.AX	Medlab Clinical Ltd	100.00%
MSB.AX	Mesoblast Ltd	-166.30%